Search by Drug Name or NDC
NDC 00299-5950-02 TRI-LUMA .1; 40; .5 mg/g; mg/g; mg/g Details
TRI-LUMA .1; 40; .5 mg/g; mg/g; mg/g
TRI-LUMA is a TOPICAL CREAM in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Galderma Laboratories, L.P.. The primary component is FLUOCINOLONE ACETONIDE; HYDROQUINONE; TRETINOIN.
MedlinePlus Drug Summary
Fluocinolone topical is used to treat the itching, redness, dryness, crusting, scaling, inflammation, and discomfort of various skin conditions, including psoriasis (a skin disease in which red, scaly patches form on some areas of the body and eczema (a skin disease that causes the skin to be dry and itchy and to sometimes develop red, scaly rashes). Fluocinolone is in a class of medications called corticosteroids. It works by activating natural substances in the skin to reduce swelling, redness, and itching.
Related Packages: 00299-5950-02Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Fluocinolone Topical
Tretinoin (Altreno, Atralin, Avita, Retin-A) is used to treat acne. Tretinoin is also used to reduce fine wrinkles (Refissa and Renova) and to improve spotty discoloration (Renova) and rough feeling skin (Renova) when used along with other skin care and sunlight avoidance programs. Tretinoin is in a class of medications called retinoids. It works by promoting peeling of affected skin areas and unclogging pores.
Related Packages: 00299-5950-02Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Tretinoin Topical
Product Information
| NDC | 00299-5950 |
|---|---|
| Product ID | 0299-5950_dcbba72f-e5b7-4688-93b7-d06478f28556 |
| Associated GPIs | 90879903253720 |
| GCN Sequence Number | 049965 |
| GCN Sequence Number Description | fluocinolone/tretinoin/h-quin CREAM (G) 0.01-.05-4 TOPICAL |
| HIC3 | L9C |
| HIC3 Description | HYPOPIGMENTATION AGENTS |
| GCN | 15815 |
| HICL Sequence Number | 023310 |
| HICL Sequence Number Description | FLUOCINOLONE ACETONIDE/TRETINOIN/HYDROQUINONE |
| Brand/Generic | Brand |
| Proprietary Name | TRI-LUMA |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | fluocinolone acetonide, hydroquinone, and tretinoin |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CREAM |
| Route | TOPICAL |
| Active Ingredient Strength | .1; 40; .5 |
| Active Ingredient Units | mg/g; mg/g; mg/g |
| Substance Name | FLUOCINOLONE ACETONIDE; HYDROQUINONE; TRETINOIN |
| Labeler Name | Galderma Laboratories, L.P. |
| Pharmaceutical Class | Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Depigmenting Activity [PE], Melanin Synthesis Inhibitor [EPC], Melanin Synthesis Inhibitors [MoA], Retinoid [EPC], Retinoids [CS] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA021112 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00299-5950-02 (00299595002)
| NDC Package Code | 0299-5950-02 |
|---|---|
| Billing NDC | 00299595002 |
| Package | 1 TUBE in 1 BLISTER PACK (0299-5950-02) / 3 g in 1 TUBE |
| Marketing Start Date | 2012-04-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |